Hypnovel clinical trials

Comparative Bioavailability of Midazolam 7.5 mg/1.5 mL Oromucosal Solution (Buccolam®) Versus Midazolam 10 mg/2 mL Solution for Injection (Hypnovel®): A Single-Dose, Open-Label, Randomized, Two-Sequence, Two-Treatment, Two-Period Crossover Study in Healthy Subjects Under Fasting Conditions.

This study is comparing two ways of giving a medicine called midazolam to healthy adults. We want to see how well the body takes in each version – one given by mouth, and one by injection – and if they act similarly. This helps us understand how different medicines work.